These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6866010)

  • 1. Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle.
    Souroujon MC; Mochly-Rosen D; Gordon AS; Fuchs S
    Muscle Nerve; 1983 May; 6(4):303-11. PubMed ID: 6866010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor in rabbit thymus: antigenic similarity between acetylcholine receptors of muscle and thymus.
    Ueno S; Wada K; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Dec; 42(3):463-9. PubMed ID: 7214741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic specificity of acetylcholine receptor in developing muscle. Studies with monoclonal antibodies.
    Souroujon MC; Pizzighella S; Mochly-Rosen D; Fuchs S
    J Neuroimmunol; 1985 May; 8(2-3):159-66. PubMed ID: 2581995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigenic structure of the acetylcholine receptor from Torpedo californica.
    Gullick WJ; Lindstrom JM
    J Cell Biochem; 1982; 19(3):223-30. PubMed ID: 6185511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
    Tzartos SJ; Sophianos D; Efthimiadis A
    J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal-type acetylcholine receptors and regulation of alpha 7 gene expression in vertebrate skeletal muscle.
    Romano SJ; Pugh PC; McIntosh JM; Berg DK
    J Neurobiol; 1997 Jan; 32(1):69-80. PubMed ID: 8989664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding site.
    Whiting P; Vincent A; Newsom-Davis J
    Eur J Biochem; 1985 Aug; 150(3):533-9. PubMed ID: 2410274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-acetylcholine-receptor antibodies directed against the cholinergic binding site.
    Mochly-Rosen D; Fuchs S
    Biochemistry; 1981 Sep; 20(20):5920-4. PubMed ID: 7295707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis.
    Lindstrom J; Einarson B
    Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas.
    Marx A; O'Connor R; Geuder KI; Hoppe F; Schalke B; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
    Lab Invest; 1990 Mar; 62(3):279-86. PubMed ID: 1690313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concanavalin-A binding to acetylcholine receptors: identification of two forms of receptor in denervated rat muscle.
    Mittag TW; Massa T
    J Pharmacol Exp Ther; 1981 Jul; 218(1):27-33. PubMed ID: 7241383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species specificity of anti-acetylcholine receptor antibodies elicited by synthetic peptides.
    Fuchs S; Neumann D; Safran A; Pizzighella S; Mantegazza R; Daniels MP; Vogel Z
    Biochemistry; 1987 Jul; 26(15):4611-6. PubMed ID: 3663612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of acetylcholine receptors: different forms of receptor distinguished by alpha-bungarotoxin kinetics and by antibody binding properties.
    Massa T; Mittag TW
    J Pharmacol Exp Ther; 1983 Nov; 227(2):340-8. PubMed ID: 6631716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies that distinguish between normal and denervated human acetylcholine receptor.
    Whiting PJ; Vincent A; Schluep M; Newsom-Davis J
    J Neuroimmunol; 1986 May; 11(3):223-35. PubMed ID: 3082932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
    Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
    Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel subpopulation of neuronal acetylcholine receptors among those binding alpha-bungarotoxin.
    Pugh PC; Corriveau RA; Conroy WG; Berg DK
    Mol Pharmacol; 1995 Apr; 47(4):717-25. PubMed ID: 7723732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species- and subtype-specific recognition by antibody WF6 of a sequence segment forming an alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor alpha subunit.
    McLane KE; Fritzen M; Wu X; Diethelm B; Maelicke A; Conti-Tronconi BM
    J Recept Res; 1992; 12(3):299-321. PubMed ID: 1507184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity.
    Lennon VA; Lambert EH
    Ann N Y Acad Sci; 1981; 377():77-96. PubMed ID: 6176167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.